Trial intelligence / Profile preview

Clonidine in Suprascapular and Costoclavicular Block vs Interscalene Block for Shoulder Surgery

NCT07256938Phase 4

Key facts

Status: Not yet recruiting
Start: Dec 2025
Primary completion: Dec 2026
Sponsor: Assiut University
Modality: Small Molecules

Drugs: clonidine
Conditions: postoperative pain

Overview

Phase 4, randomised trial of clonidine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Postoperative Pain Score. Planned start Dec 2025; status: not yet recruiting.

Design

2 arms

Study design: Randomized

Experimental Arm
Suprascapular + Costoclavicular Block + Clonidine
Control Arm
Standard Interscalene Block

Who it enrols

Adult patients (18-60 years) undergoing elective arthroscopic shoulder surgery with ASA status 1-3. Excludes patients with BMI > 40, coagulation disorders, chronic opioid/psychotropic use, or failed nerve block.

Endpoints

Primary

Postoperative Pain Score24 hours postoperative

Secondary

Intraoperative Opioid Requirementsintraoperative
Arm Motor Blockpostoperative
Diaphragmatic Paresispostoperative
Patient Satisfactionpostoperative
Time for Readiness to Discharge from PACUpostoperative

Beyond the preview

Go deeper on NCT07256938.

Full results, competitive context and analysis are in the Gosset platform.

Full results & analysis

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07256938.